Lipoprotein interactions with chromatic membranes as a novel marker for oxidative stress-related diseases

Biochimica et Biophysica Acta - Biomembranes

Volumn 1788, Issue 11, 2009, Pages 2436-2443

  Hanin Avraham, Nirit ^a   Fuhrman, Bianca ^b   Mech Dorosz, Agnieszka ^a   Kolusheva, Sofiya ^a   Porgador, Angel ^a   Aviram, Michael ^b   Jelinek, Raz ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; ARTIFICIAL MEMBRANE; CELL ASSAY; CELL MEMBRANE; CELL VACUOLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; DISEASE MARKER; GENERAL ASPECTS OF DISEASE; HUMAN; HUMAN CELL; LIPOPROTEIN METABOLISM; MALE; MEMBRANE BINDING; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PREDICTION; PRIORITY JOURNAL; PROTEIN INTERACTION;

BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FLUORESCENCE; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMANS; LIPID BILAYERS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MALE; MEMBRANE LIPIDS; MEMBRANES; MIDDLE AGED; OXIDATION-REDUCTION; OXIDATIVE STRESS;

EID: 71449118858     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2009.09.013     Document Type: Article

References (27)

1. Glass C.K., and Witztum J.L. Atherosclerosis. the road ahead. Cell 104 (2001) 503-516
2. Cardenas G.A., Lavie C.J., Cardenas V., Milani R.V., and McCullough P.A. The importance of recognizing and treating low levels of high-density lipoprotein cholesterol: a new era in atherosclerosis management. Rev. Cardiovasc. Med. 9 (2008) 239-258
3. Krentz A.J. Lipoprotein abnormalities and their consequences for patients with type 2 diabetes. Diabetes Obes. Metab. 5 Suppl. 1 (2003) S19-27
4. Tomkin G.H., and Owens D. Abnormalities of cholesterol metabolism in diabetes. Proc. Nutr. Soc. 50 (1991) 583-589
5. Matsuura E., Hughes G.R., and Khamashta M.A. Oxidation of LDL and its clinical implication. Autoimmun. Rev. 7 (2008) 558-566
6. Aviram M., Kaplan M., Rosenblat M., and Fuhrman B. Dietary antioxidants and paraoxonases against LDL oxidation and atherosclerosis development. Handb. Exp. Pharmacol. (2005) 263-300
7. Bonomini F., Tengattini S., Fabiano A., Bianchi R., and Rezzani R. Atherosclerosis and oxidative stress. Histol. Histopathol. 23 (2008) 381-390
8. Roberts C.K., and Sindhu K.K. Oxidative stress and metabolic syndrome. Life Sci. 84 21 (2009) 705-712
9. Kaneto H., Katakami N., Kawamori D., Miyatsuka T., Sakamoto K., Matsuoka T.A., Matsuhisa M., and Yamasaki Y. Involvement of oxidative stress in the pathogenesis of diabetes. Antioxid. Redox Signal. 9 (2007) 355-366
10. Yasuda M., Kobayashi T., Okada S., Matsuda H., and Nakanishi H. Chem. Phys. Lett 267 (1997) 472
11. Jelinek R., Norvez S., Okada S., and Charych D. Chem. Biol. 5 (1998) 619
12. Kolusheva S., Wachtel E., and Jelinek R. Biomimetic lipid/polymer colorimetric membranes: molecular and cooperative properties. J. Lipid Res. 44 (2003) 65-71
13. Orynbayeva Z., Kolusheva S., Livneh E., Lichtenshtein A., Nathan I., and Jelinek R. Visualization of membrane processes in living cells by surface-attached chromatic polymer patches. Angew. Chem. Int. Ed. Engl. 44 (2005) 1092-1096
14. Ringsdorf B.S.H., and Venzmer J. Angew. Chem. 27 (1988) 133
15. Orynbayena Z., Groysman O., Katz M., Kolusheva S., Khanin M., Jelinek R., and Danilenko M. Membrane processes and biophysical characterization of living cells decorated with chromatic polydiacetylene vesicles. Biochim. Biophys. Acta 1778 (2008) 1335-1343
16. Aviram M. Plasma lipoprotein separation by discontinuous density gradient ultracentrifugation in hyperlipoproteinemic patients. Biochem. Med. 30 (1983) 111-118
17. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
18. Aviram M., and Vaya J. Markers for low-density lipoprotein oxidation. Methods Enzymol. 335 (2001) 244-256
19. Pagano R.E., Martin O.C., Schroit A.J., and Struck D.K. Formation of asymmetric phospholipid membranes via spontaneous transfer of fluorescent lipid analogues between vesicle populations. Biochemistry 20 (1981) 4920-4927
20. Krieger M., and Herz J. Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu. Rev. Biochem. 63 (1994) 601-637
21. Peng S., Okada S., Spevak W., and Charych D. Color and chromism of polydiacetylene vesicles. Acc. Chem. Res. 31 (1998) 229-239
22. Rainwater D.L., Martin L.J., and Comuzzie A.G. Genetic control of coordinated changes in HDL and LDL size phenotypes. Arterioscler. Thromb. Vasc. Biol. 21 (2001) 1829-1833
23. Struck D.K., Hoekstra D., and Pagano R.E. Use of resonance energy transfer to monitor membrane fusion. Biochemistry 20 (1981) 4093-4099
24. Nichols J.W., and Angeletti C. Dithionite quenching rate measurement of the inside-outside membrane bilayer distribution of 7-nitrobenz-2-oxa-1,3-diazol-4-yl-labeled phospholipids. Biochemistry 37 (1998) 15114-15119
25. Shahal T., Kolusheva S., and Jelinek R. Peptide-membrane interactions studied by a new phospholipid/polydiacetylene colorimetric vesicle assay. Biochemistry 39 (2000) 15851-15859
26. van Antwerpen R., and Gilkey J.C. Cryo-electron microscopy reveals human low density lipoprotein substructure. J. Lipid Res. 35 (1994) 2223-2231
27. Collier W.L., Martin L.M., and van Antwerpen R. Computer-vision determination of 3-D geometric parameters of LDL particles via cryogenic transmission electron microscopy. Journal of the SID 15 (2007) 6